Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients

Methylprednisolone liver toxicity: A new case and a French regional pharmacovigilance survey

(2017) Jérôme Dumortier et al.   Clinics and Research in Hepatology and Gastroenterology

Methylprednisolone-induced liver injury: Case report and literature review

(2016) Yana Davidov et al.   Journal of Digestive Diseases

Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone

(2015) Ritu Lal et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Methylprednisolone-induced Toxic Hepatitis After Intravenous Pulsed Therapy for Multiple Sclerosis Relapses

(2015) Diana Ferraro et al.   NEUROLOGIST

Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves’ Orbitopathy

(2015) Hiroyuki Eguchi et al.   International Journal of Endocrinology

Relapse in multiple sclerosis

(2015) I. Galea et al.   BMJ-British Medical Journal

Relapse in multiple sclerosis

(2015) I. Galea et al.   BMJ-British Medical Journal

ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

(2014) Naga P Chalasani et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Methylprednisolone-induced hepatotoxicity: experiences from global adverse drug reaction surveillance

(2014) Ola Caster et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Multiple Sclerosis: Current Knowledge and Future Outlook

(2014) Christian P. Kamm et al.   EUROPEAN NEUROLOGY

Incomplete septal cirrhosis after high-dose methylprednisolone therapy and regression of liver injury

(2014) Elisabetta Grilli et al.   LIVER INTERNATIONAL

Clinical Features, Diagnosis, and Natural History of Drug-Induced Liver Injury

(2014) Robert Fontana et al.   SEMINARS IN LIVER DISEASE

Short-Term Safety of Pulse Steroid Therapy in Multiple Sclerosis Relapses

(2013) Vahid Shaygannejad et al.   CLINICAL NEUROPHARMACOLOGY

Acute liver toxicity due to methylprednisolone: Consider this diagnosis in the context of autoimmunity

(2013) P. Carrier et al.   Clinics and Research in Hepatology and Gastroenterology

Effect of High-Dose Intravenous Methyl-prednisolone Treatment on Intraocular Pressure in Multiple Sclerosis Patients with Relapse

(2012) Memed Acar et al.   EUROPEAN NEUROLOGY

Liver Injury Induced by High-Dose Methylprednisolone Therapy: A Case Report and Brief Review of the Literature

(2012) Krzysztof Gutkowski et al.   Hepatitis Monthly

Treatment of Acute Relapses in Multiple Sclerosis

(2012) Regina Berkovich   Neurotherapeutics

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Recurrent High-Dose Intravenous Methylprednisolone Succinate Pulse Therapy-Induced Hepatopathy in a Patient with Multiple Sclerosis

(2011) Daisuke Furutama et al.   MEDICAL PRINCIPLES AND PRACTICE

Hepatotoxicity After High-Dose Methylprednisolone for Demyelinating Disease

(2010) Anna Loraschi et al.   CLINICAL NEUROPHARMACOLOGY

Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: A case report

(2008) Atsushi Takahashi et al.   WORLD JOURNAL OF GASTROENTEROLOGY